Danh mục

Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST

Số trang: 9      Loại file: pdf      Dung lượng: 2.23 MB      Lượt xem: 10      Lượt tải: 0    
Jamona

Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

The Response Evaluation Criteria in Solid Tumors (RECIST) are the current standard for evaluating disease progression or therapy response in patients with solid tumors. RECIST 1.1 calls for axial, longest-diameter (or perpendicular short axis of lymph nodes) measurements of a maximum of five tumors, which limits clinicians’ ability to adequately measure disease burden, especially in patients with irregularly shaped tumors.
Nội dung trích xuất từ tài liệu:
Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST

Tài liệu được xem nhiều: